/ Glenmark Pharma's Plant Gets EIR Stock Soars 4% ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 15 March 2017

US health regulator has given establishment inspection report (EIR) to one of the plants of the drug maker, Glenmark Pharma, on Wednesday.

USFDA had inspected the Ankleshwar plant of Glenmark in Gujarat, in the month of December 2016.

The EIR is customarily issued by the FDA only if it finds the facility to be deemed acceptable.

Glenmark Pharma witnessed spurt in its volume by more than 1.9 times on Wednesday. The stock touched high of Rs 929.9 per share, being up by Rs 39 per share or 4.1%.

BSE Healthcare index is trading higher by 0.4% at 15470 levels. The stock is contributing nearly 20% to the index gains.

Fortis is the top gainer in the index, trading at Rs 183 per share, being up by 2.8%.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717